ArticleMolecular medicine (Cambridge, Mass.)2026
An efficient approach to study ANA⁺ B cells in autoimmune diseases integrating flow cytometry with single-cell analysis.
Article in Molecular medicine (Cambridge, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveSeveral autoimmune diseases are characterized by the presence of autoantibodies to nuclear antigens. They are present in essentially all patients with systemic lupus erythematosus (SLE). The study of antinuclear antibodies (ANA) produced by individual B cells can offer critical insights into the structural and functional characteristics of autoantibodies. Conventional techniques of single-cell cloning and sequencing or single-cell (Nojima) cultures have significant limitations. To overcome these limitations, we developed an integrated platform that combines flow cytometric detection of ANA-reactive B cells with an optimized single-B cell culture system.
methodsWe employed a flow cytometry assay using biotinylated nuclear extracts and fluorochrome-tagged streptavidin to detect ANA-reactive B cells, followed by single cell sorting and culture in the presence of feeder cells expressing CD40L and BAFF, IL-2 and IL-21. This integrated approach was designed to enhance clonal resolution while increasing the efficiency of ANA-specific B cell recovery compared to conventional single-cell cloning methods.
resultsWe isolated and expanded ANA + and ANA- B cells of various B cell subsets (naive, CD27 + IgM + , and IgG memory) that were isolated from healthy donors and patients with SLE. The cultures were maintained in standard conditions for 26 days at which time 82% of naïve, 53% of CD27 + IgM + and 64% of IgG⁺ memory B cells produced > 1.0 ug/mL of immunoglobulin. We further demonstrated that 88-95% of ANA + B cells Ig produced ANA-reactivity by HEp-2 staining.
conclusionsThis method establishes a robust platform for isolating and expanding ANA B cells, facilitating the production of monoclonal autoantibodies and analysis of B cell receptor (BCR) gene sequences. This expansion is achieved by culturing single ANA + B cells with CD40L-expressing feeder cells and key cytokines (BAFF, IL-2, and IL-21) which together promote their survival, proliferation, and differentiation into antibody-secreting cells. The approach offers important new potential in understanding the etiology of ANA- reactive IgG in autoimmune disease by enabling the identification of specific autoantigen targets at distinct stages of B cell differentiation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.